Werewolf Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -44.0% | -44.0% | -33.6% |
| FY2023 | -33.6% | -24.7% | -21.4% |
| FY2024 | -96.1% | -66.9% | -55.6% |
| FY2025 | -245.2% | -106.9% | -87.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -44.0% | -44.0% | -33.6% |
| FY2023 | -33.6% | -24.7% | -21.4% |
| FY2024 | -96.1% | -66.9% | -55.6% |
| FY2025 | -245.2% | -106.9% | -87.6% |